SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Directorate Change

13 Jan 2014 07:00

RNS Number : 4381X
CLS Holdings PLC
13 January 2014
Β 

Β 

Release date: 13 January 2014

Embargoed until: 7.00am

Β 

Β 

CLS Holdings plc

("CLS", the "Company" or the "Group")

Board Changes

Β 

Β 

The Board of CLS announces that Richard Tice will step down as Chief Executive Officer on 14 February 2014. Richard joined the Company in March 2010 and is leaving at his own request to spend more time with his family and pursue new challenges. The Board is pleased that he has agreed to continue to serve as a Non-Executive Director of CLS.

Β 

Henry Klotz, Executive Vice Chairman, who has been with the Group since 1999 and was Chief Executive Officer from 2008 to 2010, will take the role of Acting Chief Executive Officer. John Whiteley, Chief Financial Officer, will assume responsibility for investor relations.

Β 

CLS's executive management committee will comprise Sten Mortstedt, Henry Klotz and John Whiteley, together with non-board member Simon Wigzell, who has been promoted to Head of Group Property. In addition, Dan Howson has been promoted to Head of UK Property.

Β 

CLS continues to trade in line with the Board's expectations. At the financial year end, cash and other liquid assets were over Β£200 million and the Company expects to announce its results for the year ended 31 December 2013 on 4 March 2014.

Β 

Richard Tice, Chief Executive Officer of CLS, commented:

Β 

"I have spent almost four years at CLS and am very proud of what the management team has achieved in that period for shareholders. CLS has made significant progress in a number of areas and is extremely well placed to grow further and perform for shareholders as the market continues to improve. I will remain a committed shareholder and look forward to continuing to contribute to the CLS Board as a Non-Executive Director."

Β 

Sten Mortstedt, Executive Chairman of CLS, commented:

Β 

"We wish to thank Richard for his valuable contribution to CLS. In particular, he has built a strong management team for the business and has significantly raised the profile of CLS with investors. With a strong management team in place, a solid cash position and further improving market conditions, we look forward to the future with confidence."

Β 

-ends-

Β 

For further information, please contact:

Β 

CLS Holdings plc +44 (0)20 7582 7766

www.clsholdings.com

Sten Mortstedt, Executive Chairman

Henry Klotz, Executive Vice Chairman

Richard Tice, Chief Executive Officer

John Whiteley, Chief Financial Officer

Β 

Liberum Capital Limited +44 (0)20 3100 2222

Tom Fyson

Β 

Charles Stanley Securities +44 (0)20 7149 6000

Mark Taylor

Β 

Kinmont Limited +44 (0)20 7087 9100

Jonathan Gray

Β 

Smithfield Consultants (Financial PR) +44 (0)20 7903 0669

Alex Simmons

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOALLFFDLLIILIS
Date   Source Headline
11th Jun 20264:28 pmRNSDirector/PDMR Shareholding
2nd Jun 202610:23 amRNSDirector/PDMR Shareholding
29th May 202612:00 pmRNSTotal Voting Rights
28th May 20264:20 pmRNSDirector/PDMR Shareholding
26th May 20264:38 pmRNSTR-1: Notification of major holdings
22nd May 20265:04 pmRNSAdmission of Further Securities to Trading
15th May 20261:05 pmRNSApplication for Listing - Enhanced Scrip Dividend
13th May 202612:07 pmRNSDirector/PDMR Shareholding
30th Apr 20261:05 pmRNSDirector/PDMR Shareholding
29th Apr 20262:12 pmRNSDirector/PDMR Shareholding
27th Apr 20267:00 amRNSCLS announces sale of The Brix, Essen
23rd Apr 20264:00 pmRNSResult of AGM
16th Apr 20262:59 pmRNSScrip Dividend Reference Share Price
15th Apr 202612:32 pmRNSDirector/PDMR Shareholding
9th Apr 20263:07 pmRNSTR-1: Notification of major holdings
25th Mar 20269:58 amRNSTR-1: Notification of major holdings
23rd Mar 20264:05 pmRNSPublication of 2025 Annual Report & Notice of AGM
16th Mar 20265:46 pmRNSDirector/PDMR Shareholding
13th Mar 20263:45 pmRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSAnnual Financial Results
13th Mar 20267:00 amRNSAnnual Financial Results
10th Feb 20264:03 pmRNSDirector/PDMR Shareholding
13th Jan 20264:37 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
9th Dec 20253:12 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSTrading Update
12th Nov 20254:12 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSBoard Change/CFO Appointment
16th Oct 20257:00 amRNSCLS leases 14,700 sqm at Gotic Haus, Dortmund
10th Oct 202511:00 amRNSDirector/PDMR Shareholding
15th Sep 20259:00 amRNSTR-1 Notification of Major Holdings
9th Sep 20253:48 pmRNSDirector/PDMR Shareholding
14th Aug 20255:13 pmRNSDirector/PDMR Shareholding
13th Aug 20257:01 amRNSHalf Yearly Results Announcement 2025
13th Aug 20257:00 amRNSBoard Appointment
11th Aug 20256:11 pmRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSCLS secures over 8,000 sq. ft at The Coade
6th Aug 20257:00 amRNSCLS leases 2,165 sqm in Cologne
9th Jul 20259:49 amRNSDirector/PDMR Shareholding
3rd Jul 20251:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20251:34 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCLS sells two properties in Germany
30th Jun 202511:48 amRNSBoard Change
11th Jun 20253:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:57 pmRNSDirector/PDMR Shareholding
16th May 20254:35 pmRNSResult of AGM
13th May 20254:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.